Clinical Efficacy and Safety of Joint Butylphthalide and Human Albumin Treatment of PTCI

Source:
By:Jinjian Yang, Deqin Geng

DOI: https://doi.org/10.30564/jams.v1i1.19

Abstract:

Objective: To observe the clinical efficacy and safety of butylphthalide joint human albumin in the treatment of the progress of type in acute cerebral infarction(PTCI). Methods: 120 patients with PTCI in Department of Neurology of Shuyang People’s Hospital were used to observe the efficacy. These patients were all treated by routine medicine including anti-platelet, statins, edaravone, ginkgo leaf extract and dipyridamole after admission. According to whether used butylphthalide and(or) human albumin in the treatment of PTCI, the patients were divided into A group 30 cases, B group 45 cases, and C group 45 cases.Patients of group C were given conventional treatment. Group B were given conventional treatment and human albumin injection(5g, ivgtt, qd, 3 days in a course); Group A were treated with butylphthalide (first,with butylphthalide and sodium chloride injection 100ml, ivgtt, for 7d, then with butylphthalide soft capsules 0.2g, tid, for 21d ), human albumin(5g, ivgtt, qd, for 3d) and routine medicine. The change of NIHSS score, Barthel Index, and mRS of three groups respectively during progress,1 week, 2 weeks and 90 days after progress were observed and analyzed. Results: NIHSS score, Barthel Index, and mRS of group A, group B and group C all showed no statistically significant (all p > 0.05) on 1 week after treatment; NIHSS score and mRS of group A were both lower than group B and group C on 2 weeks and 90 days after treatment, and both of them showed statistically significant (p<0.05);  Barthel Index of group A was higher than group B and group C on 90 days after treatment,it showed statistically significant (p<0.05); The total effective rate of group A（96.7%） > group B（88.9%） > group C（77.8%),showed statistically significant (p<0.05). Conclusions: Butylphthalide joint human albumin treatment of PTCI has good therapeutic effect and safety, it is useful to clinical promotion and further research.

References:

[1] The Fourth National Conference on cerebrovascular diseases. Diagnostic points of various cerebrovascular diseases[J]. Chinese Journal of Neurology,1996,29( 6) :381-3. (in Chinese) [2] Scoring standard of clinical neurological deficit in stroke patients (1995)[J]. Chinese Journal of Neurology,1996,06:62-64. (in Chinese) [3] DaValos A, 1’oni D, 1weiIls F, et al.. Neurological deterioration in acute ischemic stroke: potential predictors and associated factors in the European cooperatiVe acute stroke study(ECASS)I[J]. Stroke,l 999,3.0:2631-2636. [4] Dá valos A, Castillo J. Potential mechanisms of worsening[J]. Cerebrovasc Dis, 1997,7(suppl 5):19-24. [5] Jie xiong, Yipu Feng. The protective effect of butylphthallde against mitochondrial injury during cerebral ischemia[J]. Acta Pharmaceutica Sinica,2000,35(6):408-412. (in Chinese) [6] Xiaoying Zheng, Wei Kong, Shumin Zhao, et al.. Effects of 3-n-butylphthalide pretreatment on microvascular architecture and free radical metabolism in hippocampus induced by cerebral ischemia/reperfusion[J]. Tianjin Medical Journal,2015,43(8):867-870. (in Chinese) [7] Ruxun Huang, Changxin Li, Liyun Chen, et al.. Effects of dl-3n-butyphthalide in the treatment of rat cerebral infarction with middle cerebral artery occlusion[J]. Chinese Journal of New Drugs,2005,14(8):985-988. (in Chinese) [8] Ping Zhang. Effects of butylphthalide on HGF expression, cognitive function and cerebral perfusion in patients with acute ischemic stroke[D]. Zhengzhou University,2016. (in Chinese) [9] Hairu Ji, Lingwei Kong, Wei Kong, et al. Effects of pretreatment with NBP on brain edema and blood brain barrier in rats during cerebral ischemia reperfusion injury[J]. Journal of Apoplexy and Nervous Diseases, 2014,31(8):698-700. (in Chinese) [10] Haoliang Xu, Yipu Feng. Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats[J]. Acta Pharmaceutica Sinica,2001,36(5):329-333. (in Chinese) [11] Liying Cui, Shunwei Li, Weiwei Zhang, et al. Effects of dl-3-butylphthalide soft capsules on treatment of acute ischemic stroke: multi-center, randomized, double-blind, double-dummy and aspirin-control study[J]. Chinese Journal of Neurology, 2008,41(11):727-730. (in Chinese) [12] Xuelan Zhang, Weijing Duan, Yanning Zhao, et al. Observation of curative effect of butylphthalide injection in treatment of progressive cerebral infarction[J]. Journal of Hebei Medical University, 2015,36(5):565-567. (in Chinese) [13] Huimin Wang, Jianshe Li, Jingjing Li. Efficacy of Butylphthalide and Sodium Chloride Injection in the treatment of anterior circulation progressive cerebral infarction[J]. Chinese Journal of Practical Nervous Diseases,2016,19(16):133. (in Chinese) [14] Hanwei Jia, Lei Jiang. Observation of curative effect of Butylphthalide and Sodium Chloride Injection in treatment of progressive cerebral infarction[J]. Chinese Journal of Practical Nervous Diseases, 2016,19(22):48-49. (in Chinese) [15] Shuqin Zhao, Zhenhao Zhang, Fang Gu. Observation of curative effect of butylphthalide on progressive cerebral infarction[J]. Journal of Apoplexy and Nervous Diseases, 2011,28(6):550-551. (in Chinese) [16] Guohua Liang, Baoyu Lai, Feng Chen, et al.. Clinical efficacy of human albumin in the treatment of progressive cerebral infarction,and its affecting factors[J]. Journal of Bengbu Medical College, 2016,41(8):1061-1063,1067. (in Chinese)